Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennie N Clough

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.
Frontline Gastroenterology|July 12, 2021
Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort studyOliver D Tavabie, Jennie N Clough, Jonathan Blackwell, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel DiseaseOmer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Journal of Crohn'S & Colitis|June 13, 2021
A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 SignallingRimma Goldberg, Jennie N Clough, Luke B Roberts, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.
Frontline Gastroenterology|July 12, 2021
Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort studyOliver D Tavabie, Jennie N Clough, Jonathan Blackwell, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel DiseaseOmer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Journal of Crohn'S & Colitis|June 13, 2021
A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 SignallingRimma Goldberg, Jennie N Clough, Luke B Roberts, et al.
Pageof 1